Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells

References

• ShankarSGanapathySSrivastavaRKGreen tea polyphenols: biology and therapeutic implications in cancerFront Biosci2007124881489917569617
   PubMed Web of Science ®Google Scholar
• LiaoSUmekitaYGuoJKokontisJMHiipakkaRAGrowth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallateCancer Lett19959622392437585463
   PubMed Web of Science ®Google Scholar
• ThangapazhamRLSinghAKSharmaAWarrenJGaddipatiJPMaheshwariRKGreen tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivoCancer Lett20072451–223224116519995
   PubMed Web of Science ®Google Scholar
• DasABanikNLRaySKFlavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytesCancer2010116116417619894226
   PubMed Web of Science ®Google Scholar
• QiaoYCaoJXieLShiXCell growth inhibition and gene expression regulation by (−)-epigallocatechin-3-gallate in human cervical cancer cellsArch Pharm Res20093291309131519784588
   PubMedGoogle Scholar
• PhilipsBJCoyleCHMorrisroeSNChancellorMBYoshimuraNInduction of apoptosis in human bladder cancer cells by green tea catechinsBiomed Res200930420721519729851
   PubMed Web of Science ®Google Scholar
• MinNYKimJHChoiJHSelective death of cancer cells by preferential induction of reactive oxygen species in response to (−)-epigallocatechin-3-gallateBiochem Biophys Res Commun20124211919722487794
   PubMedGoogle Scholar
• SenggunpraiLKukongviriyapanVPrawanAKukongviriyapanUQuercetin and EGCG exhibit chemopreventive effects in cholangiocarcinoma cells via suppression of JAK/STAT signaling pathwayPhytother Res201428684184824038588
   PubMedGoogle Scholar
• SartorLPezzatoEDonàMProstate carcinoma and green tea: (−)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP modelInt J Cancer2004112582382915386368
   PubMed Web of Science ®Google Scholar
• RamadassSKAnantharamanNVSubramanianSSivasubramanianSMadhanBPaclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cellsColloids Surf B Biointerfaces2015125657225437065
   PubMed Web of Science ®Google Scholar
• FarabegoliFPapiAOrlandiM(−)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cellsBiosci Rep20113129910820446926
   PubMed Web of Science ®Google Scholar
• BenelliRVenèRBisacchiDGarbisaSAlbiniAAnti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteasesBiol Chem2002383110110511928805
   PubMed Web of Science ®Google Scholar
• BaligaMSMelethSKatiyarSKGrowth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systemsClin Cancer Res20051151918192715756018
   PubMedGoogle Scholar
• LiHLiZXuYMEpigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cellNeurosci Bull2014301677324338484
   PubMedGoogle Scholar
• UstundagYBayraktarYCholangiocarcinoma: a compact review of the literatureWorld J Gastroenterol200814426458646619030196
   PubMed Web of Science ®Google Scholar
• SandhuDSRobertsLRDiagnosis and management of cholangiocarcinomaCurr Gastroenterol Rep2008101435218417042
   PubMedGoogle Scholar
• PatelTIncreasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United StatesHepatology20013361353135711391522
   PubMed Web of Science ®Google Scholar
• LimJHCholangiocarcinoma: morphologic classification according to growth pattern and imaging findingsAJR Am J Roentgenol2003181381982712933488
   PubMed Web of Science ®Google Scholar
• SinghPPatelTAdvances in the diagnosis, evaluation and management of cholangiocarcinomaCurr Opin Gastroenterol200622329429916550045
   PubMed Web of Science ®Google Scholar
• KhanSATaylor-RobinsonSDToledanoMBBeckAElliottPThomasHCChanging international trends in mortality rates for liver, biliary and pancreatic tumoursJ Hepatol200237680681312445422
   PubMed Web of Science ®Google Scholar
• KhanSAThomasHCDavidsonBRTaylor-RobinsonSDCholangiocarcinomaLancet20053661303131416214602
   PubMed Web of Science ®Google Scholar
• BhuiyaMRNimuraYKamiyaJClinicopathologic studies on perineural invasion of bile duct carcinomaAnn Surg199221543443491558415
   PubMedGoogle Scholar
• SoaresKCKamelICosgroveDPHermanJMPawlikTMHilar cholangiocarcinoma: diagnosis, treatment options, and managementHepatobiliary Surg Nutr201431183424696835
   PubMedGoogle Scholar
• ShenFZZhangBYFengYJCurrent research in perineural invasion of cholangiocarcinomaJ Exp Clin Cancer Res2010292420219134
   PubMed Web of Science ®Google Scholar
• ThomasMBBiological characteristics of cancers in the gallbladder and biliary tract and targeted therapyCrit Rev Oncol Hematol2007611445117164111
   PubMedGoogle Scholar
• ThomasMBSystemic and targeted therapy for biliary tract tumors and primary liver tumorsSurg Oncol Clin N Am201423236938124560115
   PubMed Web of Science ®Google Scholar
• KuhlmannJBBlumHELocoregional therapy for cholangiocarcinomaCurr Opin Gastroenterol201329332432823337933
   PubMedGoogle Scholar
• ZhangYOwusuLDuanWAnti-metastatic and differential effects on protein expression of epigallocatechin-3-gallate in HCCLM6 hepatocellular carcinoma cellsInt J Mol Med201332495996423863984
   PubMed Web of Science ®Google Scholar
• ZhangYDuanWOwusuLWuDXinYEpigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cellsInt J Mol Med201535111712425370579
   PubMed Web of Science ®Google Scholar
• HaiSKuboSUenishiTPostoperative survival in intrahepatic cholangiocarcinoma showing intraductal growthHepatogastroenterology2005526237437715816439
   PubMedGoogle Scholar
• KhanNBharaliDJAdhamiVMOral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft modelCarcinogenesis201435241542324072771
   PubMed Web of Science ®Google Scholar
• FujikiHSueokaEWatanabeTSuganumaMSynergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compoundsJ Cancer Res Clin Oncol201514191511152225544670
   PubMed Web of Science ®Google Scholar
• LangMHensonRBraconiCPatelTEpigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cellsLiver Int200929567067719226332
   PubMedGoogle Scholar